These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 20479396)

  • 41. Head and neck cancer patients treated with chemo-radiotherapy require individualized oncology nutrition.
    Kiyomoto D
    J Am Diet Assoc; 2007 Mar; 107(3):412-5. PubMed ID: 17324658
    [No Abstract]   [Full Text] [Related]  

  • 42. Why has so much chemotherapy done so little in head and neck cancer?
    Taylor SG
    J Clin Oncol; 1987 Jan; 5(1):1-3. PubMed ID: 3543232
    [No Abstract]   [Full Text] [Related]  

  • 43. [Clinical trials of combinations of molecular targeting drugs for head and neck cancer].
    Fujii M
    Gan To Kagaku Ryoho; 2008 Jul; 35(7):1122-5. PubMed ID: 18686361
    [No Abstract]   [Full Text] [Related]  

  • 44. The end of the hypoxic EPOch.
    Aguilera TA; Giaccia AJ
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):895-7. PubMed ID: 25832683
    [No Abstract]   [Full Text] [Related]  

  • 45. Cetuximab plus radiotherapy for head and neck cancer.
    Hartig F; Pechlaner C
    N Engl J Med; 2006 May; 354(20):2187; author reply 2187. PubMed ID: 16710909
    [No Abstract]   [Full Text] [Related]  

  • 46. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 2001; 19():465-83. PubMed ID: 11686028
    [No Abstract]   [Full Text] [Related]  

  • 47. Second-line chemotherapy in head and neck cancer: what should we expect?
    Büntzel J; Micke O
    Expert Rev Anticancer Ther; 2009 Mar; 9(3):269-73. PubMed ID: 19275504
    [No Abstract]   [Full Text] [Related]  

  • 48. Mucositis versus tumor control: the therapeutic index of adding chemotherapy to irradiation of head and neck cancer.
    Lee IH; Eisbruch A
    Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1060-3. PubMed ID: 19304406
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Management of cancer of the head and neck--a cocktail with your PORT?
    Saunders MI; Rojas AM
    N Engl J Med; 2004 May; 350(19):1997-9. PubMed ID: 15128901
    [No Abstract]   [Full Text] [Related]  

  • 50. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 1997; 17():428-43. PubMed ID: 9551224
    [No Abstract]   [Full Text] [Related]  

  • 51. Platinum-based concurrent chemoradiotherapy for tumors of the head and neck and the esophagus.
    Hao D; Ritter MA; Oliver T; Browman GP
    Semin Radiat Oncol; 2006 Jan; 16(1):10-9. PubMed ID: 16378902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. International Clinical Trials in Radiation Oncology. Head and neck: cancer research plan.
    Marcial VA; van den Bogaert W; Horiot JC
    Int J Radiat Oncol Biol Phys; 1988; 14 Suppl 1():S119-25. PubMed ID: 3292469
    [No Abstract]   [Full Text] [Related]  

  • 53. Combined chemotherapy and radiation in the treatment of locally advanced head and neck cancers.
    Nguyen NP; Sallah S
    In Vivo; 2000; 14(1):35-9. PubMed ID: 10757059
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exploitable mechanisms for combining drugs with radiation: concepts, achievements and future directions.
    Bentzen SM; Harari PM; Bernier J
    Nat Clin Pract Oncol; 2007 Mar; 4(3):172-80. PubMed ID: 17327857
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gene expression profiling to predict outcome after chemoradiation in head and neck cancer.
    Pramana J; Van den Brekel MW; van Velthuysen ML; Wessels LF; Nuyten DS; Hofland I; Atsma D; Pimentel N; Hoebers FJ; Rasch CR; Begg AC
    Int J Radiat Oncol Biol Phys; 2007 Dec; 69(5):1544-52. PubMed ID: 17931799
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Head and neck cancer.
    Taylor SG
    Cancer Chemother Biol Response Modif; 1988; 10():210-21. PubMed ID: 3079384
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction chemotherapy: to use or not to use? That is the question.
    Brizel DM; Vokes EE
    Semin Radiat Oncol; 2009 Jan; 19(1):11-6. PubMed ID: 19028340
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Effectiveness of the radiosensitizer cisplatin. A pilot study].
    Klima A; Szepesi S
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):457-9. PubMed ID: 3683038
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy in cancer of the head and neck.
    O'Donoghue GM; Hong WK
    Ir Med J; 1986 Jan; 79(1):20-3. PubMed ID: 2419276
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.